HOme-based Brain Monitoring With a GARment-EEG to Study Cognitive Decline in the Aging Population

NCT06993207 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-05-28

No results posted yet for this study

Summary

This study will investigate the validity of the HOGAR EEG/PSG monitoring kit designed by Bitbrain as a tool for characterizing and assessing cognitive function in older adults, as well as for detecting and predicting cognitive decline. The kit consists of two EEG headbands and a mobile computing device that allows measurements of sleep patterns (PSG) and brain activity (EEG) in a home environment.

Conditions

Interventions

DEVICE

Home Lab

The main goal is to comprehensively assess the cognitive and behavioral status of all participants, regardless of their assigned groups. Validated clinical tests (considered the gold standard) will be used, with measurements taken at participants' homes using a biosignal monitoring kit-the focal tool of the project. Whether in the control or specific groups, all participants will undergo an identical battery of tests in both the laboratory and home settings. The study design includes an introductory session for participants to understand the study's purpose and sign informed consent. Following consent, participants will have three sessions within a 3 to 6-week timeframe: one for autonomous technology use instruction and the other two for cognitive and functional evaluations.

Sponsors & Collaborators

  • Hospital Miguel Servet

    collaborator OTHER
  • Hospital Provincial Nuestra Señora de Gracia

    collaborator UNKNOWN
  • Hospital Clínico Zaragoza

    collaborator UNKNOWN
  • Universidad de Zaragoza

    collaborator OTHER
  • Instituto de Investigación Sanitaria de Aragón

    collaborator UNKNOWN
  • Bitbrain

    lead INDUSTRY

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2025-12-31
Completion
2028-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06993207 on ClinicalTrials.gov